Citigroup Inc Astrazeneca PLC Put Options Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $3.66 Million - $4.17 Million	60,000 New	60,000 $4.07 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $13.8 Million - $16.7 Million	-248,280 Reduced 89.22%	30,000 $1.99 Million
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $5.13 Million - $6.06 Million	95,000 Added 51.83%	278,280 $16.2 Million
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $10.2 Million - $11.1 Million	183,280 New	183,280 $11 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.